title: Proactive treatment appears to decrease serum immunoglobulin-E levels in patients with severe atopic dermatitis.
authors.forename: T
authors.initials: T
authors.lastname: Fukuie
authors.forename: I
authors.initials: I
authors.lastname: Nomura
authors.forename: K
authors.initials: K
authors.lastname: Horimukai
authors.forename: A
authors.initials: A
authors.lastname: Manki
authors.forename: I
authors.initials: I
authors.lastname: Masuko
authors.forename: M
authors.initials: M
authors.lastname: Futamura
authors.forename: M
authors.initials: M
authors.lastname: Narita
authors.forename: T
authors.initials: T
authors.lastname: Ohzeki
authors.forename: K
authors.initials: K
authors.lastname: Matsumoto
authors.forename: H
authors.initials: H
authors.lastname: Saito
authors.forename: Y
authors.initials: Y
authors.lastname: Ohya
mesh_terms: D000287:Administration, Topical; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000627:therapeutic use*; D001623:Betamethasone / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D003876:Dermatitis, Atopic / Q000097:blood* / Q000188:drug therapy*; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage / Q000627:therapeutic use*; D007073:Immunoglobulin E / Q000097:blood*; D007223:Infant; D008297:Male; D012189:Retrospective Studies
chemical_list: D000305:Adrenal Cortex Hormones; D007073:Immunoglobulin E; D001623:Betamethasone; D006854:Hydrocortisone